Universal Health Services said net revenues for the 3 months ended September 30, 2025 were $4.495 billion, an increase of 13.4% compared to $3.963 billion for Q3 2024, with an increase of $532 million. The company cited an increase of $431 million (11.3%) in Same Facility net revenues as a primary driver of the increase.

1. 01

   Universal Health Services said net revenues for the 3 months ended September 30, 2025 were $4.495 billion, an increase of 13.4% compared to $3.963 billion for Q3 2024, with an increase of $532 million. The company cited an increase of $431 million (11.3%) in Same Facility net revenues as a primary driver of the increase.

2. 02

   Income before income taxes (before income attributable to noncontrolling interests) for Q3 2025 increased by $155 million (46%) to $497 million, and net income attributable to UHS increased by $114 million (44%) to $373 million, the company said. For Q3 2024, the respective amounts were $342 million and $259 million.

3. 03

   Universal Health Services said Same Facility net revenues from acute care hospitals for Q3 2025 increased by $277 million (12.8%), including approximately $68 million related to the Washington, D.C. Medicaid state directed payment program covering October 1, 2024 through September 30, 2025. The company said the aggregate benefit recorded for Q3 in connection with this program was $90 million.

4. 04

   As of September 30, 2025, Universal Health Services said the available borrowing capacity under its revolving credit facility was $965 million and the aggregate principal amount of senior secured notes was $3.0 billion. The company said the book value of debt as of that date was approximately $4.7 billion and the fair value was approximately $4.5 billion.

Key figures

Quarter ended September 30, 2025

Revenue

$4.5B

Operating income

$522M

Net income

$373M

EPS

$5.86

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.